- Home
- CYD vs MGTX Comparison
CYD vs MGTX Comparison
Compare CYD & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYD
- MGTX
- Stock Information
- Founded
- CYD 1951
- MGTX 2015
- Country
- CYD Singapore
- MGTX United States
- Employees
- CYD N/A
- MGTX N/A
- Industry
- CYD Industrial Machinery/Components
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CYD Industrials
- MGTX Health Care
- Exchange
- CYD Nasdaq
- MGTX Nasdaq
- Market Cap
- CYD 609.7M
- MGTX 520.8M
- IPO Year
- CYD 1994
- MGTX N/A
- Fundamental
- Price
- CYD $21.17
- MGTX $6.34
- Analyst Decision
- CYD
- MGTX Strong Buy
- Analyst Count
- CYD 0
- MGTX 2
- Target Price
- CYD N/A
- MGTX $24.00
- AVG Volume (30 Days)
- CYD 172.3K
- MGTX 451.7K
- Earning Date
- CYD 08-11-2025
- MGTX 08-11-2025
- Dividend Yield
- CYD 2.50%
- MGTX N/A
- EPS Growth
- CYD 17.49
- MGTX N/A
- EPS
- CYD 1.12
- MGTX N/A
- Revenue
- CYD $2,621,360,849.00
- MGTX $34,508,000.00
- Revenue This Year
- CYD $6.43
- MGTX $365.04
- Revenue Next Year
- CYD $11.20
- MGTX $73.18
- P/E Ratio
- CYD $18.85
- MGTX N/A
- Revenue Growth
- CYD 6.03
- MGTX 203.23
- 52 Week Low
- CYD $8.42
- MGTX $3.85
- 52 Week High
- CYD $26.10
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- CYD 66.06
- MGTX 55.84
- Support Level
- CYD $19.09
- MGTX $6.21
- Resistance Level
- CYD $22.46
- MGTX $6.76
- Average True Range (ATR)
- CYD 1.01
- MGTX 0.39
- MACD
- CYD 0.30
- MGTX 0.08
- Stochastic Oscillator
- CYD 77.33
- MGTX 63.40
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.